https://medicalxpress.com/hiv-aids-news/ en-us Latest health news and information about HIV & AIDS The odds of human papillomavirus (HPV)-related cancers are higher among people with HIV (PWH) and solid-organ transplant recipients (SOTRs), according to a study published in JAMA Network Open. https://medicalxpress.com/news/2026-07-odds-hpv-cancers-people-hiv.html Mon, 13 Jul 2026 20:40:06 EDT news703143827 Large language models (LLMs) are only as good as the data they learn from. If their training data contains social biases, the models may unintentionally repeat those biases in their responses. As their use increases with the rise of generative AI, it has become evident that they contain biases that reinforce stereotypes based on factors like ethnicity, gender or geography. This is concerning because LLM-based chatbots have become an integral part of the health care system, where health-related stigma can negatively affect one's diagnosis and care. https://medicalxpress.com/news/2026-07-medical-ai-biased-paper.html Thu, 09 Jul 2026 08:20:05 EDT news702801724 A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV vaccine is the first to generate a high number of "broadly neutralizing" virus-fighting antibodies in primates. The research is published in the journal Nature. https://medicalxpress.com/news/2026-07-hiv-vaccine-triggers-broadly-neutralizing.html Mon, 06 Jul 2026 16:30:02 EDT news702571560 The most useful thing about a new HIV prevention guide may be a question it never asks: Why do you want to know about pre-exposure prophylaxis, or PrEP? In a pilot study at three clinics, a two-page decision aid helped people choose between a daily pill, long used to prevent HIV, and a newer injectable treatment given every two months, without requiring them to disclose details of their sex lives or explain why they wanted protection. https://medicalxpress.com/news/2026-06-hiv-stigma.html Sat, 27 Jun 2026 15:00:02 EDT news701683988 In the ongoing effort to find new therapeutics for infants born infected with the human immunodeficiency virus, an international team of investigators has discovered that babies can tolerate treatment with anti-HIV antibodies. https://medicalxpress.com/news/2026-06-hiv-bay-approach-explores-broadly.html Tue, 23 Jun 2026 09:40:03 EDT news701346396 Human immunodeficiency virus 1 (HIV-1) detection in wastewater offers a novel approach to monitor the virus in communities. Baylor College of Medicine researchers and colleagues at collaborating institutions report in Nature Communications that their method, called hybrid-capture genetic sequencing, allows them to analyze viral genomes in detail and specifically identify viral signals coming from community wastewater. https://medicalxpress.com/news/2026-06-wastewater-hidden-hiv-burden-communities.html Mon, 15 Jun 2026 16:20:13 EDT news700758118 Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives. However, a small portion of people experience detectable—and worrisome—traces of the virus that causes AIDS despite strict adherence to long-term treatment regimens and the absence of symptoms. https://medicalxpress.com/news/2026-06-defective-hiv-persistent-blood-treatment.html Mon, 08 Jun 2026 05:00:07 EDT news699868442 A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection, reports a new study led by Northwestern University that began with blood samples from people with HIV and extended into preclinical drug trials. The findings point to a potential new therapy for cognitive problems in people with HIV, with broader implications for other aging-related diseases, such as dementia. The study is published in Med. https://medicalxpress.com/news/2026-06-flu-drugs-cognitive-decline.html Fri, 05 Jun 2026 11:00:03 EDT news699781862 Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease. Some researchers have proposed that these drugs may also influence the biology of aging, but direct evidence in humans has remained limited. https://medicalxpress.com/news/2026-06-popular-glp-drug-biological-aging.html Wed, 03 Jun 2026 06:44:06 EDT news699687771 For many people living with HIV, today's treatments can suppress the virus and dramatically improve health. But even when HIV is controlled, damage to the gut caused by the disease can persist, fueling chronic inflammation linked to serious health problems. A new Tulane University study published in JCI Insight helps explain why. https://medicalxpress.com/news/2026-05-broccoli-compounds-hiv-linked-gut.html Mon, 25 May 2026 14:20:01 EDT news698933282 Scientists are tweaking a powerful cancer therapy in hopes it could fight HIV instead, by supercharging patients' own immune cells. https://medicalxpress.com/news/2026-05-small-hints-revving-immune-cells.html Tue, 12 May 2026 14:39:34 EDT news697815508 Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily doses of antiretroviral drugs. In one recent clinical study of bNAbs identified and developed into therapies at Rockefeller University, participants who received a single dose of two bNAbs maintained a nearly undetectable viral load for up to 20 weeks, and a third did so for about a year. These outcomes suggest a potential future of treatment-free, long-term control of the virus. https://medicalxpress.com/news/2026-05-hiv-reveals-mutations-antibody-therapies.html Tue, 12 May 2026 04:00:23 EDT news697777155 Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect resting immune cells. The discovery challenges a decades-old assumption in HIV biology, and opens new avenues for understanding how the virus persists in the body, despite treatment. https://medicalxpress.com/news/2026-05-hiv-hijacks-cellular-gateway-infect.html Wed, 06 May 2026 14:40:01 EDT news697288801 The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA https://medicalxpress.com/news/2026-05-fda-daily-idvynso-tablet-hiv.html Fri, 01 May 2026 22:00:02 EDT news696840037 Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University, have developed a new vaccine strategy that has generated antibodies capable of neutralizing highly divergent HIV variants. The study, published in the journal Nature, provides new insights into how the immune system can be guided towards a particularly protected part of the virus. https://medicalxpress.com/news/2026-04-hiv-vaccine-immune-viral-variants.html Wed, 29 Apr 2026 11:00:08 EDT news696671222 People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked. FIU researchers have now uncovered a previously unknown mechanism that helps explain how HIV causes emphysema and chronic obstructive pulmonary disease (COPD). https://medicalxpress.com/news/2026-04-hiv-disrupts-lung-clock-copd.html Sat, 25 Apr 2026 13:00:04 EDT news695910310 When it comes to HIV medication, many patients think they'd prefer an occasional injection over a daily pill, but uptake remains an issue, according to a Rutgers Health-led survey. When researchers surveyed 801 people living with HIV in Boston, Chapel Hill, N.C., and San Diego, 68% of respondents said they would prefer an antiretroviral shot every two months to a daily pill. Yet according to a study in the Journal of Acquired Immune Deficiency Syndromes, only 2.8% of the patients actually received such shots, even though they've been available for four years. https://medicalxpress.com/news/2026-04-hiv-shots-appeal-uptake.html Thu, 23 Apr 2026 15:00:10 EDT news696169083 Some people living with HIV develop antibodies capable of neutralizing many different strains of the virus. New research links this to immune responses that occur early in infection. The findings, published in PLOS Pathogens, come from an international research collaboration that includes the University of Gothenburg. https://medicalxpress.com/news/2026-04-hiv-earliest-immune-blood-powerful.html Tue, 21 Apr 2026 10:40:09 EDT news695985302 The human immunodeficiency virus (HIV), which is the cause of AIDS, is a master of deception, using just nine genes to hijack the complex cellular machinery of the human body. Yet, even after decades of research on how the virus replicates and persists, researchers still haven't solved the mystery of exactly which human genes influence HIV infection. https://medicalxpress.com/news/2026-04-scientists-hiv-hijacks-human-cells.html Mon, 20 Apr 2026 11:00:03 EDT news695901361 Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat. Even with effective antiretroviral therapy, immune cells infected with HIV can hide and lie inactive in certain areas of the body called latent reservoirs. If treatment is discontinued, these reservoirs may become active again, causing patients to face renewed challenges with symptoms of acquired immunodeficiency syndrome (AIDS). https://medicalxpress.com/news/2026-04-drug-effectiveness-dormant-hiv-immune.html Mon, 13 Apr 2026 17:00:08 EDT news695315881